Thabut, Dominique

Publishing since 2001 (Junior)

Has published 54 publications in 10 years

Number of publications published per year by Thabut, Dominique. (Source : PubMed)

Distribution of publications types for Thabut, Dominique. (Source : PubMed)
(a publication can be of different types, so total may exceed publications count)

Recent publications

•  Lebrec D, Thabut D, Oberti F, Perarnau JM, Condat B, Barraud H, Saliba F, Carbonell N, Renard P, Ramond MJ, Moreau R, Poynard T. Pentoxifylline Does Not Decrease Short-term Mortality but Does Reduce Complications in Patients With Advanced Cirrhosis.  Gastroenterology  2010  
•  Poynard T, Massard J, Rudler M, Varaud A, Lebray P, Moussalli J, Munteanu M, Ngo Y, Thabut D, Benhamou Y, Ratziu V. Impact of interferon-alpha treatment on liver fibrosis in patients with chronic hepatitis B: an overview of published trials.  Gastroenterol. Clin. Biol.  2009;33;10-11  
•  Ingiliz P, Chhay KP, Munteanu M, Lebray P, Ngo Y, Roulot D, Benhamou Y, Thabut D, Ratziu V, Poynard T. Applicability and variability of liver stiffness measurements according to probe position.  World J. Gastroenterol.  2009;15;27  
•  Poynard T, Benhamou Y, Thabut D, Ratziu V. Liver biopsy: the best standard...when everything else fails.  J. Hepatol.  2009;50;6  
•  Mohammadi MS, Thabut D, Cazals-Hatem D, Galbois A, Rudler M, Bonnefont-Rousselot D, Moreau R, Lebrec D, Tazi KA. Possible mechanisms involved in the discrepancy of hepatic and aortic endothelial nitric oxide synthases during the development of cirrhosis in rats.  Liver Int.  2009;29;5  
•  Izzedine H, Kheder-Elfekih R, Deray G, Thabut D. Endothelin-receptor antagonist/N-acetylcysteine combination in type 1 hepatorenal syndrome.  J. Hepatol.  2009;50;5  
•  Munteanu M, Lebray P, Massard J, Moussalli J, Varaut A, Ngo Y, Thabut D, Imbert-Bismut F, Benhamou Y, Ratziu V, Poynard T. Discordance between results of biomarkers of fibrosis shows that it is at least a "ménage à deux".  Gastroenterol. Clin. Biol.  2009;33;2  
•  Imbert-Bismut F, Naveau S, Morra R, Munteanu M, Ratziu V, Abella A, Messous D, Thabut D, Benhamou Y, Poynard T. The diagnostic value of combining carbohydrate-deficient transferrin, fibrosis, and steatosis biomarkers for the prediction of excessive alcohol consumption.  Eur J Gastroenterol Hepatol  2009;21;1  
•  Galbois A, Thabut D, Tazi KA, Rudler M, Mohammadi MS, Bonnefont-Rousselot D, Bennani H, Bezeaud A, Tellier Z, Guichard C, Coant N, Ogier-Denis E, Moreau R, Lebrec D. Ex vivo effects of high-density lipoprotein exposure on the lipopolysaccharide-induced inflammatory response in patients with severe cirrhosis.  Hepatology  2009;49;1  
•  Nguyen-Khac E, Thevenot T, Capron D, Dharancy S, Paupart T, Thabut D, Tiry C. Are ascitic electrolytes usable in cirrhotic patients? Correlation of sodium, potassium, chloride, urea, and creatinine concentrations in ascitic fluid and blood.  Eur. J. Intern. Med.  2008;19;8  

[ See timeline ] [ See all publications ]